Leukemic-derived ApoV can elicit DC-driven CD8 T cell activation (177) and the immunization of antigen-pulsed tumor-derived ApoV alone elicits a significant CD8-mediated and anti-cancer immune response in mice (47). This evidence concerns the gene CD8A and cancer.